Long-term care for older adults with schizophrenia sits at the intersection of three systems that don't talk to each other well: psychiatric care, geriatric medicine, and the long-term care industry. Many nursing homes will say they "can't take" a person with schizophrenia. Many psychiatric facilities aren't equipped to manage someone who also needs help with bathing, mobility, or feeding. Families end up navigating a fragmented landscape with high stakes.
Long-term care for older adults with schizophrenia requires a facility that can manage both psychiatric and medical needs, a thorough PASRR review, and active family advocacy to prevent inappropriate medication use and ensure quality of life.
The landscape of long-term care
Common settings include:
- Skilled nursing facilities (SNFs) — for people needing daily nursing care
- Assisted living facilities (ALFs) — for people needing help with activities of daily living but not skilled nursing
- Board-and-care or adult residential homes — typically smaller homes for people with persistent mental illness
- Memory care units — specialised dementia care
- State psychiatric hospitals or specialty psychiatric long-term care — for the smallest population with the most severe ongoing psychiatric needs
PASRR: the federal screen
Federal law requires that anyone with a serious mental illness or intellectual disability who is being admitted to a Medicaid-certified nursing facility goes through a Pre-Admission Screening and Resident Review (PASRR). The PASRR is meant to ensure two things:
- That the person actually needs nursing facility level of care
- That the facility can provide the specialised mental health services needed, or that those services are arranged separately
In practice, PASRR is a critical advocacy point for families. A thorough PASRR can document that the person needs ongoing psychiatric medication management, behavioural support, or psychotherapy — which obligates the facility to provide or arrange it.
The IMD exclusion
The federal "Institutions for Mental Diseases" (IMD) exclusion historically prevented Medicaid from paying for inpatient psychiatric care in facilities of more than 16 beds for adults aged 21-64. This rule has shaped the landscape of US mental health care for decades and is one reason that long-term psychiatric care for adults is so limited. Recent waivers and reforms have begun to soften it, but the legacy remains.
The boxed warning and antipsychotic use in long-term care
The FDA's boxed warning on antipsychotics in elderly patients with dementia-related psychosis triggered a major federal effort (the CMS National Partnership to Improve Dementia Care) to reduce inappropriate antipsychotic prescribing in nursing homes. The effort has reduced antipsychotic use in dementia patients without a clear schizophrenia indication. But it has had unintended consequences — sometimes facilities are reluctant to use antipsychotics even when they are clearly indicated for schizophrenia, or push for diagnostic changes to fit reporting requirements. Families and clinicians need to be alert to both extremes.
What to look for in a facility
- Does the facility have experience caring for residents with serious mental illness?
- Is there a psychiatrist or psychiatric nurse practitioner who sees residents regularly on site?
- How does staff respond to behavioural symptoms — do they de-escalate, or call 911 reflexively?
- What is the facility's antipsychotic prescribing rate? (Public data is available on Medicare.gov's Care Compare.)
- How are restraint and seclusion handled?
- Is there meaningful daily activity programming? Social isolation worsens schizophrenia symptoms.
- How are medical conditions coordinated with primary care?
- What is the staff turnover rate?
- What is the inspection history and complaint record?
Common problems in long-term care for schizophrenia
- Inappropriate use of antipsychotics for behavioural management of dementia, sometimes as a substitute for staffing and engagement
- Underuse of antipsychotics in people who genuinely have schizophrenia, leading to relapse
- Medication errors at admission and care transitions
- Lack of psychiatric expertise on staff
- Anticholinergic burden from layered prescriptions
- Falls from over-sedation, parkinsonism, or environmental hazards
- Inadequate dental, vision, and hearing care
- Loss of social and meaningful activity
How families can advocate
- Be present. Frequent visits at varied times reveal what care actually looks like.
- Maintain a current medication list and the contact information of all prescribers.
- Request an annual care plan meeting and attend it.
- Ask for a written rationale for any new antipsychotic, dose change, or restraint.
- Use the long-term care ombudsman program in your state — every state has one and the service is free.
- Document concerns in writing.
- Maintain or establish a psychiatric advance directive while the person has capacity.
A long-term care resident develops sudden lethargy, new falls, weight loss, or worsening confusion — these often signal an over-medication problem, infection, or other treatable medical issue.
Resources
- Medicare Care Compare — official quality data on nursing facilities
- National Consumer Voice for Quality Long-Term Care — find your state ombudsman
- NAMI family resources
- SAMHSA National Helpline — 1-800-662-4357
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.